Publications by authors named "Sabrina Rossetti"

Claim this Profile
H
Homologous recombination repair genetic testing variables and diagnostic paths for prostate cancer patients: a multicenter cohort study.
Lorena Incorvaia, Mattia Puglisi, Marco Maruzzo, Giulia Mammone, Orazio Caffo, Sabrina Rossetti

Oncologist· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The immunotherapy era in ovarian clear cell carcinoma: current evidence and future perspective.
Anna Passarelli, Sabrina Chiara Cecere, Jole Ventriglia, Carmela Pisano, Rosella De Cecio, Sabrina Rossetti

Front Immunol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The emerging role of PARP inhibitors in prostate cancer: A narrative review.
Lorenzo Lobianco, Gabriele Calvanese, Debora D'Ausilio, Sabrina Rossetti, Sabrina Chiara Cecere

Cancer Treat Rev· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Validation of the PREVES-HOR Questionnaire: A Patient-Reported Measure of Hormone Therapy-Related Quality of Life in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy.
Giuseppe Di Lorenzo, Antonio Verde, Luca Scafuri, Raffaele Baio, Francesco Grillone, Sabrina Rossetti

Oncology· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating Treatment Efficacy in Metastatic Hormone-sensitive Prostate Cancer Patients with Visceral Disease: A Systematic Review and Network Meta-analysis.
Fabiano Flauto, Giuseppe Neola, Carmine Caso, Alessio Signori, Giuseppe Fornarini, Sabrina Rossetti

Eur Urol Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Testicular Tumors and Environmental Pollution: A Comparative Oncoepidemiology Study in the Campania Region from 2020 to 2023.
Evaristo Di Napoli, Davide De Biase, Barbara Degli Uberti, Maria Dimatteo, Loredana Baldi, Sabrina Rossetti

Vet Sci· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endometrial cancer in the elderly: Characteristics, prognostic and risk factors, and treatment options.
Miriam Forte, Sabrina Chiara Cecere, Marilena Di Napoli, Jole Ventriglia, Rosa Tambaro, Sabrina Rossetti

Crit Rev Oncol Hematol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Docetaxel Versus Androgen-Receptor Signaling Inhibitors (ARSI) as Second-Line Therapy After Failure of First-Line Alternative ARSI for the Elderly ≥ 75 Years Old With Metastatic Castration-Resistant Prostate Cancer (mCRPC): A SPARTACUSS-Meet-URO 26 Real-World Study.
Anna Patrikidou, Calogero Saieva, Richard Lee-Ying, Pier Vitale Nuzzo, Talal El Zarif, Sabrina Rossetti

Clin Genitourin Cancer· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KIR2DL2/DL3+NKs and Helios+Tregs in Peripheral Blood Predict Nivolumab Response in Patients with Metastatic Renal Cell Cancer.
Sara Santagata, Anna Maria Trotta, Crescenzo D'Alterio, Maria Napolitano, Giuseppina Rea, Sabrina Rossetti

Clin Cancer Res· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of First-Line Abiraterone Acetate or Enzalutamide for Older Adults With Metastatic Castration-Resistant Prostate Cancer According to Use of Upfront Docetaxel for Metastatic Castration-Sensitive Prostate Cancer in an International Multicenter Registry: A SPARTACUSS-Meet-URO 26 Study.
Giuseppe Fotia, Calogero Saieva, Richard Lee-Ying, Anna Patrikidou, Pier Vitale Nuzzo, Sabrina Rossetti

Clin Genitourin Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of Health-Related Quality of Life Reporting in Phase III RCTs of Advanced Genitourinary Tumors.
Fabrizio Di Costanzo, Fabiana Napolitano, Fabio Salomone, Anna Rita Amato, Gennaro Alberico, Sabrina Rossetti

Cancers (Basel)· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic body radiotherapy with CyberKnife System for low- and intermediate-risk prostate cancer: clinical outcomes and toxicities of CyPro Trial.
Valentina Borzillo, Esmeralda Scipilliti, Donato Pezzulla, Marcello Serra, Gianluca Ametrano, Sabrina Rossetti

Front Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unilateral post-chemotherapy robot-assisted retroperitoneal lymph node dissection in Stage II non-seminomatous germ cell tumor: A tertiary care experience.
Dario Franzese, Antonio Tufano, Alessandro Izzo, Raffaele Muscariello, Giovanni Grimaldi, Sabrina Rossetti

Asian J Urol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of cabazitaxel in octogenarian prostate cancer patients.
Paolo Tralongo, Sebastiano Bordonaro, Giuseppe Di Lorenzo, Ugo De Giorgi, Nicolò Borsellino, Sabrina Rossetti

Curr Urol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of immunotherapy treatment in non-clear cell renal cell carcinoma: An analysis of the literature.
Jole Ventriglia, Anna Passarelli, Carmela Pisano, Sabrina Chiara Cecere, Sabrina Rossetti

Crit Rev Oncol Hematol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line treatment of metastatic castration-resistant prostate cancer: the real-world Italian cohort of the Prostate Cancer Registry.
Luca Galli, Vincenzo Emanuele Chiuri, Giuseppe Di Lorenzo, Salvatore Pisconti, Sabrina Rossetti

Tumori· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes of volume of disease on patients receiving enzalutamide abiraterone acetate plus prednisone as first-line therapy for metastatic castration-resistant prostate cancer.
Pier Vitale Nuzzo, Francesco Ravera, Calogero Saieva, Elisa Zanardi, Giuseppe Fotia, Sabrina Rossetti

Ther Adv Med Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical impact of volume of disease and time of metastatic disease presentation on patients receiving enzalutamide or abiraterone acetate plus prednisone as first-line therapy for metastatic castration-resistant prostate cancer.
Pier Vitale Nuzzo, Filippo Pederzoli, Calogero Saieva, Elisa Zanardi, Giuseppe Fotia, Sabrina Rossetti

J Transl Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The way to precision medicine in gynecologic cancers: The first case report of an exceptional response to alpelisib in a -mutated endometrial cancer.
Anna Passarelli, Jole Ventriglia, Carmela Pisano, Sabrina Chiara Cecere, Marilena Di Napoli, Sabrina Rossetti

Front Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting immunometabolism mediated by the IDO1 Pathway: A new mechanism of immune resistance in endometrial cancer.
Anna Passarelli, Carmela Pisano, Sabrina Chiara Cecere, Marilena Di Napoli, Sabrina Rossetti

Front Immunol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reirradiation of Locally Recurrent Prostate Cancer with Cyberknife System or Volumetric Modulated Arc Therapy (VMAT) and IGRT-Clarity: Outcomes, Toxicities and Dosimetric Evaluation.
Rossella Di Franco, Valentina Borzillo, Esmeralda Scipilliti, Gianluca Ametrano, Marcello Serra, Sabrina Rossetti

Cancers (Basel)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Achieving Consensus for Management of Hormone-Sensitive, Low-Volume Metastatic Prostate Cancer in Italy.
Elena Verzoni, Giovanni Pappagallo, Filippo Alongi, Stefano Arcangeli, Giulio Francolini, Sabrina Rossetti

Curr Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of Metastatic Disease in Campania (MAMETIC): An Observational Multicenter Retrospective and Prospective Trial on Palliative Radiotherapy in an Italian Region. Study Protocol.
Rossella Di Franco, Marco Cascella, Mario Fusco, Valentina Borzillo, Esmeralda Scipilliti, Sabrina Rossetti

J Pain Res· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oligometastatic prostate cancer treatment.
Sabrina Rossetti, Marilena Di Napoli, Carmela Pisano, Sabrina C Cecere, Rosa Tambaro

Future Oncol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Docetaxel and prednisone with or without enzalutamide as first-line treatment in patients with metastatic castration-resistant prostate cancer: CHEIRON, a randomised phase II trial.
Orazio Caffo, Cinzia Ortega, Franco Nolè, Donatello Gasparro, Claudia Mucciarini, Sabrina Rossetti

Eur J Cancer· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis